Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Journal of Molecular Histology|March 17, 2010
Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodiesMarcus Franz, Bernhard R Brehm, Petra Richter, et al.
International Journal of Molecular Sciences|November 9, 2017
Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?Ilonka Rohm, Katja Grün, Linda Marleen Müller, et al.
Cancer Research|January 8, 2011
E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical modelsEzia Bello, Gennaro Colella, Valentina Scarlato, et al.
Oncotarget|November 12, 2016
Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expressionMarcus Franz, Katja Grün, Stefan Betge, et al.
Blood|August 23, 2003
Selective targeted delivery of TNFalpha to tumor blood vesselsLaura Borsi, Enrica Balza, Barbara Carnemolla, et al.
Histochemistry and Cell Biology|February 10, 2009
Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinomaMarcus Franz, Karin Spiegel, Claudia Umbreit, et al.
International Journal of Cardiology|September 4, 2013
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosisMarcus Franz, Alexander Berndt, Dario Neri, et al.
Cardiovascular Research|July 18, 2024
Extra domain A-containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibodyIsabell Singerer, Laura Tempel, Katja Gruen, et al.
International Journal of Cardiology|June 10, 2015
Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectinMarcus Franz, Fabia Doll, Katja Grün, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2013
Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectinMarcus Franz, Ingrid Hilger, Katja Grün, et al.
Pageof 10